AIRO Group Holdings, Inc.
AIRO Nasdaq Aircraft Financials FY2024βFY2025
What AIRO Group Holdings, Inc. does
No business description yet.
- Legal name
- AIRO Group Holdings, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 31, 2026
- Accession Β· CIK
- 0001493152-26-014116
0001927958
Revenue and margins
AIRO Group Holdings, Inc. had $90.9M of revenue in fiscal 2025, up 4.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$35.5M in fiscal 2025, β39.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
AIRO Group Holdings, Inc. returned $19.4M to shareholders in fiscal 2025. The diluted share count rose 44.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably AIRO Group Holdings, Inc. can carry it.
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $20.9M | $74.6M |
| Debt incl. finance leases | $34.7M | $2.9M |
| Debt / equity | 0.1x | 0.0x |
| Interest coverage | β | β7.4x |
| Current ratio | 0.4x | 3.4x |
| Quick ratio | 0.3x | 3.1x |
| Total assets | $701M | $774M |
| Total liabilities | $152M | $34.9M |
| Shareholders' equity | $549M | $739M |
| Net debt (β = net cash) | $13.7M | β$71.7M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | β | β |
| Cash from operations is positive | β | β |
| Return on assets rose | β | β |
| Cash from operations exceeds net income | β | β |
| Debt fell relative to assets | β | β |
| Current ratio rose | β | β |
| Share count didn't rise | β | β |
| Gross margin rose | β | β |
| Revenue rose relative to assets | β | β |
| F-score | β / 3 | 3 / 9 |
| Accruals ratio | β8.6% | 3.8% |
| Altman Z'' | 2.15 | 21.71 |
2 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | $86.9M | $90.9M |
| Gross profit | $58.3M | $54.4M |
| Research and development | $13.1M | $17.9M |
| Operating income | β$17.4M | β$28.8M |
| Interest expense | β | $3.9M |
| Pretax income | β$29.5M | $2.9M |
| Income tax | $9.2M | $7.0M |
| Net income | β$38.7M | β$4.1M |
| Diluted EPS | β$2.36 | β$0.17 |
| Diluted shares | 0.00B | 0.00B |
| Cash flow | ||
| Cash from operations | $21.5M | β$32.4M |
| Capital expenditure | $0.8M | $3.1M |
| Free cash flow | $20.7M | β$35.5M |
| Depreciation and amortization | $12.6M | $12.0M |
| Stock-based compensation | $0.7M | $19.9M |
| Share buybacks | β | $19.4M |
| Dividends and buybacks | β | $19.4M |
| Balance sheet | ||
| Cash and short-term investments | $20.9M | $74.6M |
| Total debt | $34.7M | $2.9M |
| Current assets | $42.6M | $106M |
| Current liabilities | $96.6M | $30.9M |
| Inventory | $8.8M | $11.6M |
| Property and equipment, net | $6.8M | $9.0M |
| Goodwill | $558M | $572M |
| Intangible assets | $93.5M | $83.5M |
| Total assets | $701M | $774M |
| Total liabilities | $152M | $34.9M |
| Shareholders' equity | $549M | $739M |
| Margins | ||
| Gross margin | 67.1% | 59.9% |
| Operating margin | β20.1% | β31.6% |
| EBITDA margin | β5.5% | β18.4% |
| Net margin | β44.5% | β4.5% |
| FCF margin | 23.8% | β39.1% |
| Returns | ||
| Return on capital | β2.4% | β2.8% |
| Return on capital employed | β2.9% | β3.9% |
| Return on equity | β7.1% | β0.6% |
| Return on assets | β5.5% | β0.6% |
| Return on tangible equity | β | β4.9% |
| Growth | ||
| Revenue growth | β | 4.6% |
| FCF growth | β | β271.6% |
| Share count change | β | 44.5% |
| Financial health | ||
| Debt / equity | 0.1x | 0.0x |
| Interest coverage | β | β7.4x |
| Current ratio | 0.4x | 3.4x |
| Quick ratio | 0.3x | 3.1x |
| Capital allocation | ||
| Capex / revenue | 0.9% | 3.4% |
| Stock comp / revenue | 0.8% | 21.9% |
| Quality scores | ||
| Piotroski F-score | β | 3.0 |
| Altman Z'' | 2.2 | 21.7 |
| Accruals ratio | β8.6% | 3.8% |
Source: SEC EDGAR XBRL filings (CIK 0001927958). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.